Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 23
|
pp. 25453–25465
A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients
Back to article
Figure 7
(7 of 8)
−
100%
+
Figure 7.
Sensitivity of low- or high-risk patients to five common chemotherapy agents.
The
y
-axis represents 50% inhibitory concentration (IC
50
). (
A
) Bexarotene; (
B
) Bicalutamide; (
C
) Bortezomib; (
D
) Bryostatin; (
E
) Rapamycin.
